trial · primary record
Dostarlimab
Ovarian Neoplasms
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 198 |
| Primary completion | 2029-12-31 |
| Primary endpoint | Progression Free Survival |
| Registry ID | NCT06023862 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:46:03.045Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06023862
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Dostarlimab · compound